ResMed (MEX:RMD) FFO


MEX:RMD ResMed Inc MEX:RMD
99 GF Score
Price MXN3,716.10
GF Value MXN5,298.64
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is ResMed FFO?

FFO (Funds from operations) only applies to REITs.

MEX:RMD
99GF Score
ResMed Inc MEX:RMD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ResMed (MEX:RMD) Overvalued in 2026?

Based on GuruFocus' analysis, ResMed stock appears to be undervalued. The current stock price of MXN3,716.10 is trading 29.9% below its estimated GF Value™ of MXN5,298.64. GuruFocus considers ResMed to be Significantly Undervalued.

Key valuation signals for MEX:RMD:

  • FFO:
  • GF Value™: MXN5,298.64 vs. price of MXN3,716.10 (29.9% below fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ResMed Business Description

Address 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score

Get the complete analysis for MEX:RMD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,716.10
Price
MXN5,298.64
GF Value